Proprietary Autophagy Modulators

About Biophagy

Biophagy is a private, preclinical-stage biotech founded in 2016, pioneering a novel approach to treating neurodegenerative diseases and aging-related conditions by modulating the cellular autophagy process. The company operates a dual business model, combining proprietary drug development for high unmet medical needs with a direct-to-consumer wellness product, CellWatch™. Led by a team of seasoned pharmaceutical entrepreneurs and scientists, Biophagy is positioned at the intersection of cutting-edge biology and therapeutic development, though it faces significant risks inherent to novel drug discovery and a competitive landscape.

Therapeutic Areas